Fidelity Investments’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.2M Sell
5,971,666
-2,517,977
-30% -$33.3M ﹤0.01% 1281
2026
Q1
$117M Sell
8,489,643
-857,539
-9% -$12.9M 0.01% 1104
2025
Q4
$169M Buy
9,347,182
+3,286,326
+54% +$59M 0.01% 943
2025
Q3
$112M Sell
6,060,856
-100,446
-2% -$1.58M 0.01% 1130
2025
Q2
$98.6M Sell
6,161,302
-3,763,915
-38% -$67.1M 0.01% 1129
2025
Q1
$193M Sell
9,925,217
-696,127
-7% -$14.7M 0.01% 811
2024
Q4
$234M Buy
10,621,344
+5,004,587
+89% +$96.3M 0.01% 759
2024
Q3
$94.6M Buy
5,616,757
+3,239,307
+136% +$48.1M 0.01% 1125
2024
Q2
$28.4M Buy
+2,377,450
New +$26.6M ﹤0.01% 1525
2023
Q4
Sell
-2
Closed -$15 5464
2023
Q3
$15 Buy
+2
New +$15 ﹤0.01% 5126
2022
Q2
Sell
-488,684
Closed -$3.13M 4963
2022
Q1
$3.13M Buy
+488,684
New +$3.24M ﹤0.01% 2485

Other funds holding CLBT

Fidelity Investments's CLBT Position: Q2 2026 in Review

Fidelity Investments reduced its Cellebrite (CLBT) stake by 30% in Q2 2026, selling an estimated $33.3M and leaving 5,971,666 shares worth $87.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1281.

Fidelity Investments first reported a position in CLBT in Q1 2022 and has held it in 11 quarters since. The position peaked at $234M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Fidelity Investments held 5,971,666 shares of Cellebrite worth $87.2M as of Q2 2026.
  • Fidelity Investments sold 2,517,977 Cellebrite shares in Q2 2026, an estimated $33.3M.
  • Cellebrite made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1281 holding.
  • Fidelity Investments first reported a position in Cellebrite in Q1 2022 and has held it in 11 quarters since.
  • Fidelity Investments's Cellebrite position peaked at $234M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.